Papers

Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinoma

Authors: Pan, Y., Q. Zhu, T. Hong, J. Cheng, and X. Tang.
PubYear: 2024
Journal: Aging-US